Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.43 USD | -2.41% | +6.11% | +3.40% |
09/05 | Lixte Biotechnology Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
23/04 | Lixte Biotechnology Files Up to $50 Million Mixed Shelf | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+3.40% | 5.47M | |
+64.23% | 62.59B | |
-2.31% | 41.18B | |
+44.36% | 40.29B | |
-8.29% | 27.9B | |
+11.97% | 26.21B | |
-21.16% | 19.09B | |
+7.54% | 13.08B | |
+27.17% | 12.05B | |
+25.72% | 12.26B |
- Stock Market
- Equities
- LIXT Stock
- News Lixte Biotechnology Holdings, Inc.
- LIXTE Biotechnology Gets Approval for Soft Tissue Sarcomas Treatment Trial